Combining therapies for alcohol use and liver disease
Integrated therapies for alcohol use and ALD (ITAALD) Network -UofL Clinical Center
This study is looking at new ways to help people with alcohol-related liver problems and alcohol use issues by combining therapy and medication to improve their overall health and well-being.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisville NIH-funded |
| Lab location | 1 site (Louisville, United States) |
| Project ID | NIH-11078954 on NIH RePORTER |
What this research studies
This research investigates integrated therapies for patients suffering from alcohol-associated liver disease (ALD) and alcohol use disorder (AUD). It aims to develop a comprehensive treatment approach that combines behavioral therapies and medical interventions to improve patient outcomes. The study will explore the effectiveness of existing medications and novel therapies, while also addressing the stigma associated with alcohol misuse that can hinder treatment. By focusing on both the physical and psychological aspects of these conditions, the research seeks to enhance the quality of care for affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with alcohol-associated liver disease or severe alcohol-associated hepatitis who are seeking treatment.
Not a fit: Patients with liver disease not related to alcohol consumption or those who are not actively seeking treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective treatment options for patients with alcohol-associated liver disease, potentially improving survival rates and quality of life.
How similar studies have performed: Previous studies have shown promising results with integrated approaches to treating alcohol use and liver disease, indicating potential for success in this research.
Where this research is happening
Louisville, United States
- University of Louisville — Louisville, United States (Active)
Researchers
- Principal investigator: Mcclain, Craig J. — University of Louisville
- Study coordinator: Mcclain, Craig J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.